Takayuki Shiratsuchi

Operating Officer & General Manager of Basic Research, Otsuka Pharmaceutical Co., Ltd.

Takayuki Shiratsuchi is Operating Officer and General Manager of Basic Research at Otsuka Pharmaceutical Co., Ltd., a Japan-based, global pharmaceutical company that focuses on pharmaceutical products for the treatment of diseases, and nutraceutical products for the maintenance of everyday health. In this role, he is responsible for all basic research at the company.

From 2011 through January 2015, Shiratsuchi was Chief Operating Officer and then Chief Executive Officer of Otsuka Maryland Medicinal Laboratories (OMML), Otsuka’s main research institute in the U.S. Earlier, Shiratsuchi was a researcher and a director in various research institutes at Otsuka. His research and managerial engagement spanned oncology, immunology, vaccinology, molecular biology and genetics.

At the University of Tokyo, Shiratsuchi earned a bachelor’s degree, a master’s degree from the Graduate School of Pharmaceutical Sciences and a Ph.D. from the Graduate School of Medicine.